To view PDF documents
External links included in this website should not be construed as an official endorsement of the views contained therein.
|
What's New
January 2013
- Pharmacy Diversion Awarness Conferences
- 30-Day Notice - Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Application for Procurement Quota for Controlled
Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Report of Mail Order Transaction (February 8, 2013)
- GE
Healthcare (February 6, 2013)
- Sanjay Trivedi, M.D.; Decision and Order (February 4, 2013)
- 30-Day Notice - Comments Requested: Application for Registration Under Domestic
Chemical Diversion Control Act of 1993 and Renewal Application for
Registration Under Domestic Chemical Diversion Control Act of 1993; DEA
Forms 510 and 510a (January 30, 2013)
- 30-Day Notice - Comments Requested: Annual Reporting Requirement for Manufacturers of
Listed Chemicals (January 30, 2013)
- PCAS-Nanosyn, LLC (January 30, 2013)
- Mylan
Technologies, Inc. (January 29, 2013)
- Alkermes Gainesville, LLC (January 29, 2013)
- Fisher
Clinical Services, Inc. (January 25, 2013)
- Importer of Controlled Substances; Notice of Application (January 25, 2013)
- R & D
Systems, Inc. (January 25, 2013)
- Myoderm (January 25, 2013)
- Chattem Chemicals, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (January 25, 2013)
- Johnson Matthey, Inc. (January 25, 2013)
- Ampac Fine Chemicals, LLC (January 25, 2013)
- Siegfried (USA) (January 25, 2013)
- Chemic Laboratories, Inc. (January 25, 2013)
- Noramco, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Morton Grove Pharmaceuticals (January 25, 2013)
- Order With Opportunity for Comment - Exempt Chemical Preparations Under the Controlled Substances Act (January 22, 2013)
- 30-Day Notice - Comments Requested: Collection of Laboratory Analysis Data on Drug
Samples Tested by Non-Federal (State and Local) Crime Laboratories (January 14, 2013)
- 60-Day Notice - Comments Requested: Reporting and Recordkeeping for Digital
Certificates (January 11, 2013)
- Establishment of Drug Codes for 26 Substances (January 4, 2013)
December 2012
- ISP
Freetown Fine Chemicals (December 27, 2012)
- Disposal of Controlled Substances (December 21, 2012)
- Hospira (December 21, 2012)
- Fisher Clinical Services, Inc. (December 21, 2012)
- AMRI Rensselaer, Inc. (December 21, 2012)
- Rhodes Technologies (December 21, 2012)
- Euticals, Inc. (December 21, 2012)
- Chemtos, LLC (December 21, 2012)
- Halo Pharmaceutical, Inc. (December 21, 2012)
- Schedules of Controlled Substances: Placement of Lorcaserin Into
Schedule IV (December 19, 2012)
- Stephanie A. Tarapchak, M.D.; Decision and Order (December 11, 2012)
- Robert M. Brodkin, D.P.M.; Decision and Order (December 11, 2012)
- Pharmacy Diversion Awareness Conference - Indianapolis, Indiana (December 8 & 9, 2012)
- 60-Day Notice - Comments Requested: Report of Mail Order Transaction (December 7, 2012)
- Jeffery J. Becker, D.D.S., and Jeffery J. Becker, D.D.S.,
Affordable Care Decision and Order (December 5, 2012)
- Amy S. Benjamin, N.P.; Decision and Order (December 5, 2012)
- Mylan
Pharmaceuticals, Inc. (December 5, 2012)
- Fisher
Clinical Services, Inc. (December 5, 2012)
- Siemens Healthcare Diagnostics, Inc. (December 5, 2012)
- ISP
Inc (December 5, 2012)
- 60-Day Notice - Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine (December 4, 2012)
- 60-Day Notice - Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 250 (December 4, 2012)
November 2012
- Johnson
Matthey, Inc. (November 27, 2012)
- Siegfried (USA), LLC (November 27, 2012)
- Norac (November 27, 2012)
- 60-Day Notice - Comments Requested: Application for Registration Under Domestic
Chemical Diversion Control Act of 1993 and Renewal Application for
Registration Under Domestic Chemical Diversion Control Act of 1993 DEA
Forms 510 & 510A (November 26, 2012)
- 60-Day Notice - Comments Requested: Annual Reporting Requirement for Manufacturers of
Listed Chemicals (November 26, 2012)
- Cerilliant Corporation (November 23, 2012)
- Lipomed, Inc. (November 23, 2012)
- Mylan
Technologies, Inc. (November 23, 2012)
- Cayman Chemical Company (November 23, 2012)
- Alltech Associates, Inc. (November 23, 2012)
- Boehringer Ingelheim Chemicals, Inc. (November 23, 2012)
- Cayman Chemical Company (November 23, 2012)
- Cambrex Charles City, Inc. (November 23, 2012)
- Karen Paul Holley, M.D.; Decision and Order (November 15, 2012)
- 21st National Conference on Pharmaceutical and Chemical Diversion - Cincinnati, Ohio (November 14-15, 2012)
- Wayne D. Longmore, M.D.; Decision and Order (November 13, 2012)
- Larry Elbert Perry, M.D.; Decision and Order (November 13, 2012)
- Fernando Valle, M.D.; Decision and Order (November 13, 2012)
- Watson
Pharma, Inc. (November 13, 2012)
- SA
INTL GMBH C/O., Sigma Aldrich Co., LLC. (November 13, 2012)
- Cedarburg Pharmaceuticals, Inc. (November 13, 2012)
- Johnson Matthey Inc. (November 13, 2012)
- Wildlife Laboratories, Inc. (November 13, 2012)
- Nektar Therapeutics (November 13, 2012)
- Fisher
Clinical Services, Inc. (November 9, 2012)
- Boehringer Ingelheim Chemicals, Inc. (November 9, 2012)
- Noramco, Inc. (November 9, 2012)
- Johnson Matthey, Inc. (November 9, 2012)
- Cody Laboratories, Inc. (November 9, 2012)
- National Center For Natural Products Research (NIDA MPROJECT) (November 9, 2012)
- INB
Hauser Pharmaceutical Services, Inc. (November 9, 2012)
October 2012
- 60-Day Notice - Comments Requested: Collection of Laboratory Analysis Data on Drug Samples Tested by
Non-Federal (State and Local Government) Crime Laboratories (October 30, 2012)
- Jose Gonzalo Zavaleta, M.D.; Denial of Application (October 18, 2012)
- Zvi H. Perper, M.D., Decision and Order (October 18, 2012)
- Noramco, Inc. (October 18, 2012)
- ISP
Freetown Fine Chemicals (October 18, 2012)
- Akorn,
Inc. (October 18, 2012)
- Noramco, Inc. (October 18, 2012)
- Cambridge Isotope Lab (October 18, 2012)
- Chattem Chemicals, Inc. (October 18, 2012)
- Lin Zhi International, Inc. (October 18, 2012)
- Chemica (October 18, 2012)
- Schedules of Controlled Substances: Extension of Temporary
Placement of Methylone Into Schedule I of the Controlled Substances Act (October 18, 2012)
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I (October 17, 2012)
- 30-Day Notice - Comments Requested: Application for Registration; Application for Registration Renewal; Affidavit for Chain Renewal; Application for Modification of Registration for Online Pharmacies DEA Forms 224, 224a, 224b, 224c (October 15, 2012)
- 30-Day Notice - Comments Requested: Application for Import Quota for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 (October 15, 2012)
- 30-Day Notice - Comments Requested: Import/Export Declaration for List I and List II
Chemicals; DEA Forms 486 and 486A (October 15, 2012)
- Holiday CVS, L.L.C., d/b/a CVS/Pharmacy Nos. 219 and 5195;
Decision and Order (October 12, 2012)
- Holiday CVS, L.L.C., d/b/a CVS/Pharmacy Nos. 219 and 5195; Denial
of Request for Redactions (October 12, 2012)
- Fisher
Clinical Services, Inc. (October 2, 2012)
- Cody
Laboratories, Inc. (October 2, 2012)
- United
States Pharmacopeial Convention (October 2, 2012)
- Chemic Laboratories, Inc. (October 2, 2012)
- Morton Grove Pharmaceuticals (October 2, 2012)
- Sigma Aldrich Research Biochemicals, Inc. (October 2, 2012)
- AMPAC Fine Chemicals,
LLC. (October 2, 2012)
- ISP, Inc. (October 2, 2012)
- Apertus Pharmaceuticals, LLC. (October 2, 2012)
- Established Aggregate Production Quotas for Schedule I and II
Controlled Substances and Established Assessment of Annual Needs for
the List I Chemicals Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2013 (October 1, 2012)
September 2012
- Correction: Definitions Relating to Electronic Orders and Prescriptions for Controlled Substances (September 24, 2012)
- Rene Casanova, M.D.; Decision and Order (September 19, 2012)
- Cleveland J. Enmon, Jr., M.D.; Decision and Order (September 17, 2012)
- Henri Wetselaar, M.D.; Decision and Order (September 17, 2012)
- T.J. Mcnichol, M.D.; Decision and Order (September 17, 2012)
- Final Rule: Consolidation of Seizure and Forfeiture Regulations (September 12, 2012)
- Controlled Substances: Final Adjusted Aggregate Production Quotas
for 2012 (September 10, 2012)
- Final Adjusted Assessment of Annual Needs for the List I
Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2012 (September 10, 2012)
- Cambrex Charles City, Inc. (September 10, 2012)
- Research Triangle Institute (September 10, 2012)
- Noramco, Inc. (September 10, 2012)
- Alltech Associates, Inc. (September 10, 2012)
- AMPAC Fine Chemicals LLC. (September 10, 2012)
August 2012
- Arizona Department of Corrections (August 29, 2012)
- Cerilliant Corporation (August 29, 2012)
- Euticals Inc. (August 29, 2012)
- Austin Pharma, LLC. (August 29, 2012)
- Agilent Technologies (August 29, 2012)
- American Radiolabeled Chemicals, Inc. (August 29, 2012)
- Stepan Company (August 29, 2012)
- Almac
Clinical Services, Inc. (August 20, 2012)
- Catalent Pharma Solutions, Inc. (August 20, 2012)
- Research Triangle Institute (August 20, 2012)
- Cody Laboratories, Inc. (August 20, 2012)
- Lipomed (August 20, 2012)
- Clinical Supplies Management, Inc. (August 20, 2012)
- SA INTL
GMBH C/O., Sigma Aldrich Co., LLC (August 20, 2012)
- Cerilliant Corporation (August 20, 2012)
- R & D
Systems, Inc. (August 20, 2012)
- Sai Wentum, M.D.; Decision and Order (August 15, 2012)
- 60-Day Notice -
Comments Requested: Import/Export Declaration for List I and List II
Chemicals; DEA Forms 486 and 486A (August 9, 2012)
- 60-Day Notice -
Comments Requested: Application for Import Quota for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine DEA Form 488 (August 9, 2012)
- 60-Day Notice - Comments Requested: Application for Registration; Application for
Registration Renewal; Affidavit for Chain Renewal; Application for
Modification of Registration for Online Pharmacies DEA Forms 224, 224a,
224b, 224c (August 7, 2012)
- Physicians Pharmacy, L.L.C.; Decision and Order (August 7, 2012)
- SA
INTL GMBH C/O., Sigma Aldrich Co. LLC (August 7, 2012)
- Lipomed (August 7, 2012)
- Cerilliant Corporation (August 7, 2012)
- Clinical Supplies Management Inc. (August 7, 2012)
- R &
D Systems, Inc. (August 7, 2012)
- Research Triangle Institute (August 7, 2012)
- Catalent Pharma Solutions, Inc. (August 7, 2012)
- Halo Pharmaceutical Inc. (August 7, 2012)
- AMRI
Rensselaer, Inc. (August 7, 2012)
- Cayman Chemical
Company (August 7, 2012)
- Chemtos, LLC. (August 7, 2012)
- Penick Corporation (August 7, 2012)
- Cambrex Charles City, Inc. (August 7, 2012)
- Proposed Aggregate Production Quotas for Schedule I and II
Controlled Substances and Proposed Assessment of Annual Needs for the
List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine
for 2013 (August 3, 2012)
- Decision and Order; Perry T. Dobyns, M.D. (August 1, 2012)
- James William Eisenberg, M.D.; Decision and Order (August 1, 2012)
- Margy Temponeras, M.D.; Decision and Order (August 1, 2012)
- Electronic Prescriptions for Controlled Substances Notice of
Approved Certification Process (August 1, 2012)
|
|
